首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Atherosclerosis plus

缩写:ATHEROSCLEROSIS PLUS

ISSN:2667-0909

e-ISSN:2667-0895

IF/分区:2.1/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引142
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Hadjer Namous,Maria Giuseppina Strillacci,Camila Urbano Braz et al. Hadjer Namous et al.
Background and aim: The complex dynamic interplay between different biological pathways involved in atherosclerosis development has rendered the identification of specific therapeutic targets a challenging quest. We aimed...
Muhammad Omar Larik Muhammad Omar Larik
Background and aims: Calcific aortic valve disease (CAVD) is a common valvular disease, prevalent particularly within the older age groups. The potential use of biomarkers in diagnosing and assessing the severity of CAVD,...
Edita Pogran,Paul M Haller,Claudia Wegberger et al. Edita Pogran et al.
Background and aims: It is suggested that the changes in atherosclerosis happen mainly under the influence of non-fasting lipids. To date, the studies in the postprandial state were primarily performed on healthy subjects...
Dhairya Nanavaty,Rhea Green,Ankushi Sanghvi et al. Dhairya Nanavaty et al.
Background and aims: Prediabetes is defined as a state of impaired glucose metabolism with hemoglobin A1c (HbA1c) levels that precede those of a diabetic state. There is increasing evidence that suggests that hyperglycemi...
Anastasios Makris,Antonia Pagkali,Emmanouil Nikolousis et al. Anastasios Makris et al.
Background and aims: To systematically investigate all relevant evidence on the association between high-density lipoprotein cholesterol (HDL-C) and multiple myeloma (MM). ...
Anastasios Makris,Fotios Barkas,Petros P Sfikakis et al. Anastasios Makris et al.
Background and aims: Lipoprotein(a) [Lp(a)] and interleuking-6 (IL-6), an inflammation biomarker, have been established as distinct targets of the residual atherosclerotic cardiovascular disease (ASCVD) risk. We aimed to ...
Menno Hoekstra,Miranda Van Eck Menno Hoekstra
Background and aims: Non-alcoholic fatty liver disease (NAFLD), a high incidence liver pathology, is associated with a ∼1.5-fold higher cardiovascular disease risk. This phenomenon is generally attributed to the NAFLD-as...
Morten Hjuler Nielsen,Rikke Bæk,Malene Moller Jorgensen et al. Morten Hjuler Nielsen et al.
Background and aims: OxLDL modulates innate and adaptive immunity, and extracellular vesicles (EVs) released from both non-immune and immune cells are proposed key players in atherosclerosis development. In the present st...
Lotta Ulander,Piia Simonen,Heli Tolppanen et al. Lotta Ulander et al.
Background and aims: To evaluate the effect of hydroxychloroquine (HCQ) on serum and lipoprotein lipids and serum biomarkers of cholesterol synthesis and absorption in myocardial infarction patients with a high-dose stati...
Winfried März,Nina Schmidt,Ira An Haack et al. Winfried März et al.
Background and aims: Familial hypercholesterolemia (FH) is among the most common genetic disorders in primary care. However, only 15% or less of patients are diagnosed, and few achieve the goals for low-density lipoprotei...